Poster Abstract Session:
178. Clostridium difficile
Saturday, October 5, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Tracks: Adult ID, Epidemiology and Infection Control

Presentations:

Community-Acquired Clostridium difficile Infection is more common than Hospital-Onset in Hospitalized Patients – A Two-Year Retrospective Study
Harold Lin, MD, MS ; Raed Khoury, MA, MPH ; Thomas Lam, MD ; Hishida Kurt, BSN, CIC ; Krickett Pal, RN ; Elisa Porter, BA ; Dee Lacy, MD, Ph.D
Posters
  • Abstract40684.png (232.8 kB)

  • Stool Cytotoxicity Activity Correlates with Immune Competency in Patients with C. difficile Infection
    Fredy Chaparro-Rojas, MD ; Jennifer Delacruz, MD ; Randee Estes, BS ; Kathleen Mullane, DO, FIDSA ; David Pitrak, MD
    Posters
  • Abstract#40610.pdf (913.4 kB)

  • Diagnosis and Management of Clostridium difficile Infection by Pediatric Infectious Diseases Physicians
    Julia Shaklee Sammons, MD, MSCE ; Jeffrey S. Gerber, MD, PhD ; Pranita D. Tamma, MD, MHS ; Thomas J. Sandora, MD, MPH ; Ritu Banerjee, MD, PhD ; Susan E. Beekmann, RN, MPH ; Philip M. Polgreen, MD ; Adam L. Hersh, MD, PhD
    Posters
  • Sammons ID Week_sized.pdf (518.6 kB)

  • Utility of Repeating a Clostridium difficile PCR Test within 7 Days of a Negative Result
    Guo Jun Huang, MD ; Rekha Sivadas, MD ; Silvia Spitzer, PhD ; Eric Spitzer, M.D., Ph.D.
    Posters
  • GJH-poster-1363- final.pdf (7.2 MB)

  • Inappropriate Clostridium difficile infection (CDI) testing increased CDI rates without identifying carriers of C. difficile at risk for transmission or recurrence
    Sirisha Kundrapu, M.D. ; Venkata C.K. Sunkesula, M.D., M.S ; Abhishek Deshpande, M.D., Ph.D. ; Curtis J. Donskey, MD
    Posters
  • ID Week 2013 poster 2.png (426.4 kB)

  • A Clostridium difficile Infection (CDI) Stewardship Initiative Decreases Inappropriate CDI Testing and Reduces Delays in Diagnosis
    Lucy Jury, N.P. ; Brett Sitzlar, B.S. ; Myreen E. Tomas, MD ; Sirisha Kundrapu, M.D. ; Sudha Nagalingam, MD ; Curtis J. Donskey, MD

    Clostridium difficile at Long Term Care Facilities-Are We Testing  Enough?
    Amina Pervaiz, MD ; Paul Lephart, PhD ; Theodore Theodoroff ; Reda A. Awali, MD, MPH ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Teena Chopra, MD, MPH
    Posters
  • IDSA_CDI_Testing_Pervaiz.pdf (776.9 kB)

  • Hospitalwide Asymptomatic and Symptomatic Clostridium difficile (CD) Infection (CDI) Surveillance by Realtime PCR
    Hoonmo L. Koo, MD ; John Van, BA ; Meina Zhao, PhD ; Xunyan Ye, PhD ; Zhi-Dong Jiang ; Carolyn Grimes, DrPH, BSMT (ASCP) ; Diana C. Koo, MPA ; Todd M. Lasco, PhD ; Margaret Price, PHD ; Kevin Garey, PharmD ; Herbert Dupont, MD, FIDSA
    Posters
  • IDWeek 2013.pdf (262.4 kB)

  • Evaluation of the Risk Factors Associated with Severe Clostridium difficile Infection (CDI) in a Veterans Affairs Hospital
    Ursula C. Patel, PharmD, BCPS AQ-ID ; Jerry L. Tuazon, PharmD ; Jeffrey T. Wieczorkiewicz, PharmD, BCPS ; Todd A. Lee, PharmD, PhD

    Does Alkaline Colonic pH Predispose to Clostridium difficile Infection?
    Purba Gupta, MD ; Stanley Yakubov, MD ; Kevin Tin, MD ; Olga Garankina, MD ; Manali Pednekar, MD ; Diego Zea, MD ; Farah Chinwalla, DO ; Khawar Khurshid, MD ; Maxine Seales, MD ; Yu Shia Lin, MD ; Monica Ghitan, MD ; Edward Chapnick, MD ; Michael Koegel, MD

    Examining the relationship between fluoroquinolone use and Clostridium difficile infections (CDI): A meta-analysis
    Michelle Formanek, MS ; Loreen A. Herwaldt, MD, FIDSA, FSHEA ; Jennifer Mcdanel, MS ; Amy Blevins, MALS ; Marin Schweizer, PhD

    Shared Hoppers: A novel risk factor for the transmission of Clostridium difficile
    Julie A. Choudhuri, RN MSPH ; Jeannie D. Chan, PharmD, MPH ; Matthew J. Hafermann, PharmD ; Charlotte Fulton, RN MHA ; Elizabeth Melius, RN MN MPH ; Astrid B. Schreuder, PhD ; Elizabeth Mcnamara, RN MN ; Ronald Pergamit, MPA ; John B. Lynch, MD MPH ; Timothy H. Dellit, MD
    Posters
  • TSICU_CDIFF_FINAL092513.pdf (356.6 kB)

  • Identification of “High” Risk Population for Future Clostridium difficile Infection (CDI)
    James Baggs, PhD ; Kimberly Yousey-Hindes, MPH, CPH ; Elizabeth Dodds-Ashley, PharmD, MHS ; James Meek, MPH ; Ghinwa Dumyati, MD, FSHEA ; Jessica Cohen, MPH ; Matthew Wise, PhD ; L. Clifford Mcdonald, MD ; Fernanda Lessa, MD

    Pre-admission Predictors of Clostridium difficile Infection (CDI) in Residents Receiving Long-term Care at Veterans Affairs Facilities
    Jeanmarie Mayer, MD ; Makoto Jones, MD, MS ; Susan M. Pacheco, MD ; Dale N. Gerding, MD ; Curtis J. Donskey, MD ; Molly Leecaster, PhD ; Matthew Maw, MS ; Kevin Nechodom, BS ; Matthew Samore, MD

    Risk factors for complications of Clostridium difficile Infection in a prospective multicentre cohort
    Claire Nour Abou Chakra, MSc ; Annie-Claude Labbé, MD, FRCPC ; Allison McGeer, MD, MSc, FRCPC, FSHEA ; Andrew E. Simor, MD, FRCPC, FACP ; Wayne Gold, MD ; Roslyn Devlin ; Kevin Katz, MD CM, MSc ; Jeff Powis, MD, MSc, FRCPC ; Louis-Charles Fortier, PhD ; Matthew P. Muller, MD, PhD, FRCPC ; Julian R. Garneau, BSc ; Jacques Pepin, MD ; Louis Valiquette, MD, MSc

    Evaluating the presence of Clostridium difficile in the household environment and its role in disease transmission, Minnesota, 2011-2012
    Stacy Holzbauer, DVM, MPH, DACVPM ; Judith Noble-Wang, PhD ; Fernanda Lessa, MD ; Jessica Cohen, MPH ; Alicia Shams, MPH ; Lydia Anderson, BS ; L. Clifford Mcdonald, MD ; Kirk Smith, DVM, PhD ; Ruth Lynfield, MD

    Clinical and molecular characterization of Clostridium difficile isolated in a university hospital in Japan: a retrospective study
    Nobuaki Mori, M.D., Ph.D. ; Sadako Yoshizawa, MD, PhD ; Tomoo Saga, M.D., Ph.D ; Yoshikazu Ishii, Ph.D. ; Kazuhiro Tateda, M.D, Ph.D

    Epidemiology of Clostridium difficile infection (CDI) in Queensland, Australia
    Lisa Hall, PhD ; Charlotte Huber, PhD ; Mareeka Gray, RN ; Michelle Allen ; Leisha Richardson ; Narelle George ; Graeme Nimmo, MD, PhD ; Thomas Riley, MD, PhD ; David L. Paterson, MD PhD
    Posters
  • 1381_IDWPOSTER.pdf (2.0 MB)

  • Changing epidemiology of healthcare-associated Clostridium difficile infection from 3 years study in Korea
    Jieun Kim, MD ; Hyunjoo Pai, MD ; Mi-Ran Seo ; Jung Oak Kang, MD ; Tae Yeal Choi, MD
    Posters
  • 2013-IDSA-È®ÀåÇü-2.pdf (334.4 kB)

  • The Impact of Clostridium difficile-associated Diarrhea on the Healthcare Utilization of Older and Chronically Ill Patients
    Edward Drozd, PhD ; Shamonda Braithwaite, MBA ; Hemal Shah, PharmD ; Sheila Thomas, PharmD

    Incidence and Mortality Associated with Clostridium difficile Infection at a Japanese Tertiary Care Center
    Hitoshi Honda, MD ; Akinori Yamazaki, PharmD ; Yumiko Sato, RN, CIC ; Erik Dubberke, MD, MSPh
    Posters
  • IDSA presentation 2013 CDI .pdf (139.0 kB)

  • INCREMENTAL LENGTH OF STAY AND COSTS ASSOCIATED WITH HOSPITALIZATION FOR CLOSTRIDIUM DIFFICILE INFECTION
    Shelagh Szabo, MSc ; Adrian Levy, PhD ; Greta Lozano-Ortega ; Elisa Lloyd-Smith, PhD ; Victor Leung, MD, FRCPC ; Tracey Ramsay ; Marc G. Romney, MD, FRCPC, DTM&H

    The Economic Burden of Clostridium difficile-associated Diarrhea: A Retrospective Study of Acute Care Hospital Inpatients, 2009-2011
    Glenn Magee, MBA ; Harold Brown, MHA / MBA ; Marcie Strauss, MPH ; Sheila Thomas, PharmD

    Using an Agent-Based Simulation Model to Conduct an Economic Analysis of Strategies to Control Clostridium difficile Transmission and infection
    Richard E. Nelson, PhD ; Makoto Jones, MD, MS ; Molly Leecaster, PhD ; William Ray ; Angela Huttner, MD ; Benedikt Huttner, MD ; Karim Khader, PhD ; Jose Campo, MD ; Dale Gerding, MD, FIDSA ; Matthew Samore, MD ; Michael Rubin, MD, PhD

    The Economic Burden of Clostridium difficile infection in Canada
    Adrian Levy, PhD ; Shelagh Szabo, MSc ; Greta Lozano-Ortega ; Elisa Lloyd-Smith, PhD ; Victor Leung, MD, FRCPC ; Marc G. Romney, MD, FRCPC, DTM&H

    Effectiveness of spray application of a novel sporicidal disinfectant cleaner
    Abhishek Deshpande, M.D., Ph.D. ; Thriveen Mana, M.S., MBA ; Jennifer Cadnum, B.S. ; Brett Sitzlar, B.S. ; Dennis Fertelli ; Sirisha Kundrapu, M.D. ; Venkata C.K. Sunkesula, M.D., M.S ; Alex Polinkovsky, Ph.D. ; Curtis Donskey, MD

    Effectiveness of a sporicidal peracetic acid/hydrogen peroxide-based daily disinfectant cleaner for disinfection of floors in rooms of patients with Clostridium difficile infection
    Abhishek Deshpande, M.D., Ph.D. ; Thriveen Mana, M.S., MBA ; Annette Jencson, BSMT(ASCP)SM, CIC ; Jennifer Cadnum, B.S. ; Brett Sitzlar, B.S. ; Dennis Fertelli ; Kelly Hurless, B.S. ; Sirisha Kundrapu, M.D. ; Venkata C.K. Sunkesula, M.D., M.S ; Curtis Donskey, MD

    Frequent environmental contamination with Clostridium difficile after routine cleaning and disinfection of hospital rooms: a multi-hospital study
    Abhishek Deshpande, M.D., Ph.D. ; Brett Sitzlar, B.S. ; Dennis Fertelli ; Jennifer Cadnum, B.S. ; Priyaleela Thota, MD ; Erica Pozwick ; Sirisha Kundrapu, M.D. ; Venkata Sunkesula, M.D, M.S ; Amy Ray, MD ; Robert Salata, MD ; Curtis Donskey, MD

    More Cleaning, Less Screening:  Evaluation of the Time Required for Monitoring Versus Performing Daily Environmental Cleaning    
    Sirisha Kundrapu, M.D. ; Venkata C.K. Sunkesula, M.D., M.S ; Abhishek Deshpande, M.D., Ph.D. ; Curtis J. Donskey, MD

    A Veterans Affairs (VA) Initiative to Prevent Healthcare-Associated Clostridium difficile Infections (CDI)
    Martin Evans, MD ; Stephen Kralovic, MD, MPH ; Loretta Simbartl, MS ; Rajiv Jain, MD ; Gary Roselle, MD

    Analysis of questionnaire results from the pilot C. difficile Prevention Collaborative of New York State, 2011-2012
    Michelle L. March, MPH ; Monica Quinn, RN, MS, CIC ; Nicole Spencer Bryan, MPH, CPH, CIC ; Valerie B. Haley, MS ; Emily C. Lutterloh, MD, MPH

    Thirty- Day Readmissions due to Clostridium difficile Infection-What Do We Know?
    Paru Patel, Pharm D ; Sarit Sharma, MD ; Teena Chopra, MD, MPH
    Posters
  • CDI Poster_IDW_Sarit Sharma.pdf (717.5 kB)

  • The Epidemiology of Clostridium difficile Infection (CDI) in Patients with Frequent Interfacility Transfers
    Reda Awali, MD, MPH ; Vallabh Karpe, MD ; Bharat Marwaha, MD ; Muhammad Bilal Asghar, MD ; Fatima Motiwala, MD ; Amina Pervaiz, MD ; Urooj Qazi, MD ; Ranbir Singh, MD ; Sravya Dasyam, MD ; Tejasvi Sunkara, MD ; Teena Chopra, MD, MPH
    Posters
  • IDSA_OPTIMER_Awali.pdf (1.1 MB)

  • The Addition of Intravenous Metronidazole to Oral Vancomycin Improves Mortality in Critically Ill Patients with Clostridium difficile Infection (CDI)
    Kristina Rokas, PharmD ; James Johnson, PharmD ; James Beardsley, PharmD ; Christopher Ohl, MD ; Vera Luther, MD ; John Williamson, PharmD
    Posters
  • CDI IDWeek Poster FINAL.pdf (212.0 kB)

  • Clostridium difficile infection (CDI) treatment practices in San Francisco County, 2012
    Erin P Garcia, MPH, CPH ; Erin Parker, MPH ; Joelle Nadle, MPH ; Lisa G Winston, MD
    Posters
  • CEIP_Garcia.pdf (169.7 kB)

  • The Effect of Routine Fecal Microbiota Transplantation (FMT) on Healthcare-facility Associated Clostridium difficile Infection: A Mathematical Modeling Approach
    Eric Lofgren, MSPH, PhD ; Rebekah W. Moehring, MD, MPH ; Deverick J. Anderson, MD, MPH ; David J. Weber, MD, MPH, FIDSA, FSHEA ; Nina Fefferman, PhD
    Posters
  • SER_FMT.pdf (4.4 MB)

  • Adherence and Recurrence Rates of C. difficile Infection After a 6-Week Tapering Regimen of Oral Vancomycin Solution
    Susan Jacobson, MD ; Han Wang, PharmD ; Kelvin Chan, PharmD ; Tania Chopra, PharmD
    Posters
  • 1408_IDWPOSTER .pdf (447.5 kB)

  • Whole Genome Sequencing Demonstrates Fidaxomicin Prevents C. difficile Relapse and Reinfection
    David Eyre, BM BCh ; Farah Babakhani, PhD ; David Griffiths, BSc ; Jaime Seddon, BS ; Tim Peto, DPhil ; A. Sarah Walker, PhD ; Derrick Crook, MB BCh
    Posters
  • Fdx_Recurrence_Final.pdf (2.9 MB)

  • The Use of Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) in Patients with Cancer
    Amin Esmaily-Fard, PharmD ; Frank Tverdek, PharmD ; David Crowther ; Shashank S. Ghantoji, MD, MPH ; Javier A. Adachi, MD, FIDSA ; Roy Chemaly, MD, MPH

    Vitamin D: The “feel-better” drug for Clostridium difficile infection?
    Ken Koon Wong, MD ; Rebecca Lee, MD ; Richard Watkins, MD, MS ; Nairmeen Haller, Ph.D

    Health Care Workers at Long –term Care Facilities-How much do they know about Clostidium diffiicle Infection?
    Reda Awali, MD, MPH ; Sudha Sadasivan, PhD ; Pragnesh Patel, MD ; Bharat Marwaha, MD ; Caitlin Biedron, M.S. ; Preethy Samuel, PhD ; Teena Chopra, MD, MPH
    Posters
  • IDSA_CDI_Knowledge_Awali.pdf (491.5 kB)

  • Colonization with C. difficile in Long-term Care Facility Residents in Two Veterans Affairs Community Living Centers
    Susan M. Pacheco, MD ; Curtis J. Donskey, MD ; Matthew Samore, MD ; Jeanmarie Mayer, MD ; Nimalie D. Stone, MD, MS ; Carolyn V. Gould, MD, MS ; L. Clifford Mcdonald, MD ; Laurica A. Petrella, BS ; Susan Sambol, MT ; Annette Jencson, BSMT(ASCP)SM, CIC ; Deborah Terry ; Venkata C.K. Sunkesula, M.D., M.S ; Dale N. Gerding, MD

    Identification of Asymptomatic Clostridium difficile Colonization among Healthy Adults
    Alison Galdys, MD ; Scott Curry ; Kathleen Shutt, MS ; Lee Harrison, MD
    Posters
  • 20130925IDSAPosterAG.pdf (182.4 kB)

  • Comparison of multilocus variable-number tandem-repeat analysis (MLVA) and whole genome sequencing (WGS) to confirm or refute Clostridium difficile infection (CDI) case clusters
    Warren Fawley, PhD ; David Eyre, BM BCh ; David Griffiths, BSc ; Derrick Crook, MB BCh ; Tim Peto, DPhil ; A. Sarah Walker, PhD ; Mark Wilcox, MD

    Outbreak of Clostridium difficile in a Teaching Hospital in Guatemala City
    Johanna Samayoa, MD ; Claudia Cosenza, MD ; Carlos Mejia, MD ; Elvia Soto, GN ; Ingrid Gudiel, GN ; Remei Gordillo, MLT ; Rosa Cortes, MLT ; Diego Erdmenger, MD ; Luis O'connell, MD ; Iris Cazali
    Posters
  • POSTER CLOSTRIDIUM digital.jpg (472.5 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.